Northeastern University and Massachusetts Biotechnology Council to host drug discovery day

October 14, 2004

WHO: The Massachusetts Biotechnology Council (MBC) Drug Discovery Committee and Northeastern University invite you to a new event in drug discovery technology. With the variety of new tools and knowledge available today to more rapidly develop advanced therapies, we have the "critical mass" in the Boston area to lead the world in drug discovery.

WHAT: Alexandros Makriyannis, PhD, Behrakis Trustee Chair in Pharmaceutical Biotechnology and Director, The Center for Drug Discovery, Northeastern University. Dr. Makriyannis comes to Northeastern this fall after 30 years at University of Connecticut and will continue his work on novel medications, drug mechanisms of action, and new therapeutic drug technologies.

Abbie Celniker, PhD, Senior Vice President of R & D Strategy and Operations, Millennium Pharmaceuticals, Inc. (MPI). In this role, Dr. Celniker is responsible for the oversight of the pipeline portfolio and project management activities at MPI. Prior to joining MPI, Dr. Celniker was the Assistant Vice President of Biotherapeutic Research Technologies at the Genetics Institute division of Wyeth Ayerst Research and prior to that was a Senior Scientist/Associate Director in the Medicinal and Analytical Chemistry department at Genentech, Inc.

WHERE: Monday, October 18, 2004 1 pm to 7 pm
Northeastern University, Curry Student Center

WHEN: 1:00 -7:00 pm
1:00 Registration Opens
1:30 First Keynote - Alexandros Makriyannis
2:15 Poster Session Opens
4:30 Second Keynote - Abbie Celniker

TO ATTEND: E-mail your name, title and company to Include 10/18 Drug Discovery in the subject line.
Contact Lisa Woods at the MBC with questions at 617-577-8198 x207.

Northeastern University

Related Drug Discovery Articles from Brightsurf:

December special issue of SLAS Discovery features 'drug discovery targeting COVID-19'
The December edition of SLAS Discovery, ''Drug Discovery Targeting COVID-19'' is a special collection assembled by Associate Editor Timothy Spicer (Scripps, FL, USA), focusing on drug discovery efforts toward the current global pandemic of COVID-19caused by the novel coronavirus, SARS-CoV-2.

New cell profiling method could speed TB drug discovery
A new cell profiling technology combines high throughput imaging and machine learning to provide a rapid, cost-effective way to determine how specific compounds act to destroy the bacterium that causes tuberculosis.

An open-access tool to accelerate drug discovery
The Chemical Checker provides processed, harmonized and ready-to-use bioactivity information on more than 1M small molecules.

New macrolactone database could aid drug discovery, research
Researchers have created a free-to-use database of 14,000 known macrolactones -- large molecules used in drug development -- which contains information about the molecular characteristics, chemical diversity and biological activities of this structural class.

Discovery of a drug to rescue winter depression-like behavior
A group of animal biologists and chemists at the Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, has used a chemical genomics approach to explore the underlying mechanism of winter depression-like behavior and identified a drug that rescues winter depression-like behavior in medaka fish.

Fat-fighting drug discovery
Cancer-fighting compound fights obesity and diabetes.

New cell models for ocular drug discovery
Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery.

Machine learning's next frontier: Epigenetic drug discovery
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images -- allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental illness and more.

Discovery of how colorectal cancer drug works will help more patients
Some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown.

Speeding up the drug discovery process to help patients
An international research team is perfecting a method to predict the potential clinical implications of new drugs before clinical trials even start.

Read More: Drug Discovery News and Drug Discovery Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to